Bahrain vs Turkey: Cause of death, by non-communicable diseases, ages 5-14, male
Bahrain
54.0%
in 2021
Turkey
52.5%
in 2021
Bahrain rank
42nd
Turkey rank
45th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Bahrain
- Turkey
How they compare
Bahrain currently reports 54.0% against 52.5% in Turkey, a difference of 1.5%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Turkey ahead.
Bahrain ranks 42nd and Turkey ranks 45th of 185 countries.
Across the 3 decades both report, Bahrain averaged higher in 1 and Turkey in 2.
Head to head by decade
| Decade | Bahrain | Turkey | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 43.9% | 44.9% | 1.0% | Turkey |
| 2010s | 52.9% | 53.3% | 0.4% | Turkey |
| 2020s | 54.9% | 53.1% | 1.8% | Bahrain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Bahrain or Turkey?
- Bahrain, at 54.0% against 52.5% in Turkey as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Bahrain and Turkey?
- 1.5%, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Turkey?
- 6 years are reported by both, from 2000 to 2021.
- How do Bahrain and Turkey rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Bahrain ranks 42nd and Turkey ranks 45th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.